Waters Corporation stock surges 41.5% over the past year, fueled by strong demand for chromatography and mass spectrometry systems, outpacing sector benchmarks and rival Agilent Technologies.
Waters Corporation is the primary subject, and the article highlights its strong demand, double-digit growth, and outperformance relative to sector peers and the benchmark ETF.
Agilent Technologies is mentioned as a rival with mixed performance, lagging Waters over 52 weeks but slightly outperforming on a year-to-date basis.
The Health Care Select Sector SPDR ETF is used as a benchmark, and Waters is noted as outperforming it across all reported timeframes.
Waters Corporation (WAT) shares reached a 52-week high of $431.78, driven by robust demand for lab equipment and double-digit growth in its diagnostics segment. The company continues to outperform the Health Care Select Sector SPDR ETF (XLV), supported by strategic acquisitions and strong pharmaceutical sector demand.
Growth is primarily driven by strong demand for lab equipment, routine testing supplies, and a 40% surge in GLP-1 testing, alongside successful acquisitions and cost-saving initiatives.